Andritz AG
XMUN:AZ2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Andritz AG
XMUN:AZ2
|
AT |
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
First Community Bankshares Inc
NASDAQ:FCBC
|
US |
|
P
|
Paccar Inc
F:PAE
|
US |
|
E
|
EDP Energias de Portugal SA
ELI:EDP
|
PT |
|
Elekta AB (publ)
F:EJXB
|
SE |
|
C
|
Cal-Comp Electronics Thailand PCL
SET:CCET
|
TH |
Wall St Price Targets
AZ2 Price Targets Summary
Andritz AG
According to Wall Street analysts, the average 1-year price target for AZ2 is 87.55 EUR with a low forecast of 74.31 EUR and a high forecast of 98.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AZ2's stock price target?
Price Target
87.55
EUR
According to Wall Street analysts, the average 1-year price target for AZ2 is 87.55 EUR with a low forecast of 74.31 EUR and a high forecast of 98.71 EUR.
What is the Revenue forecast for Andritz AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 7 years is 6%.
What is the Operating Income forecast for Andritz AG?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 7 years is 9%.
What is the Net Income forecast for Andritz AG?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is 14%.
